Rocket Pharmaceuticals: Peers

The FY2023 (Dec) proxy of Rocket Pharmaceuticals names 16 peer companies for pay. Among Rocket Pharmaceuticals and these peers, CEO pay was the highest of 4 and total shareholder return was 2nd highest of 4.

1st highest of 4in Rocket Pharmaceuticals and its pay peers, FY2023 (Dec) by CEO pay:

$3.6M$8.0M

2nd highest of 4in Rocket Pharmaceuticals and its pay peers, FY2023 (Dec) by total shareholder return:

$44$145

Pay peer group, FY2023 (Dec) proxy

Beam Therapeutics
Regenxbio
Replimune Group
AgiosNot disclosedNot disclosed
AllogeneNot disclosedNot disclosed
AmicusNot disclosedNot disclosed
Bluebird bioNot disclosedNot disclosed
BridgeBioNot disclosedNot disclosed
CRISPR AGNot disclosedNot disclosed
EditasNot disclosedNot disclosed
IntelliaNot disclosedNot disclosed
KrystalNot disclosedNot disclosed
MiratiNot disclosedNot disclosed
RhythmNot disclosedNot disclosed
TenayaNot disclosedNot disclosed
UltragenyxNot disclosedNot disclosed
16 companies

Changes by year

FY2024 (Dec) proxy

  • RemovediQure N.V.pay peer group

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.